[Chronic total coronary occlusions: an overview]

Rosario Fiorilli1, Francesco De Felice, Roberto Violini

  • 1U.O. di Cardiologia Interventistica, A.O. San Camillo-Forlanini, Roma. rosario.fiorilli@tiscali.it

Giornale Italiano Di Cardiologia (2006)
|February 14, 2007
PubMed

Insights

Chronic total coronary occlusion (CTO) treatment via percutaneous coronary intervention is challenging but offers improved survival and cardiac function. Stenting, especially with drug-eluting stents, reduces restenosis rates for CTOs.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Biology

Context:

  • Chronic total coronary occlusion (CTO) affects approximately one-third of diagnostic catheterizations.
  • Many CTOs are untreated or managed with coronary bypass surgery due to intervention challenges.
  • Percutaneous coronary interventions (PCI) for CTOs face low success rates, high costs, and restenosis concerns.

Purpose:

  • To review the challenges and benefits of percutaneous recanalization for chronic total coronary occlusions.
  • To identify criteria justifying interventional approaches for CTOs.
  • To discuss the role of stent implantation and drug-eluting stents in improving CTO treatment outcomes.

Summary:

  • CTO is a >3-month obstruction of a coronary artery, histologically characterized by fibro-atheromatous plaque and thrombus.
  • Interventional treatment is indicated for CTOs with demonstrated ischemia or myocardial viability and favorable angiographic features.
  • Procedural failure in CTO PCI is often due to the inability to cross the lesion with a guidewire.

Impact:

  • Successful CTO revascularization improves long-term survival, reduces symptoms, enhances left ventricular function, and decreases the need for coronary bypass surgery.
  • Stent implantation significantly lowers restenosis rates compared to balloon angioplasty alone.
  • Drug-eluting stents show potential for further improving long-term results in CTO treatment.

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...